Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity

Modified vaccinia Ankara (MVA) is a safe and promising viral vaccine vector that is currently investigated in several clinical and pre-clinical trials. In contrast to inactivated or sub-unit vaccines, MVA is able to induce strong humoral as well as cellular immune responses. In order to further impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauterbach, Henning, Pätzold, Juliane, Kassub, Ronny, Bathke, Barbara, Brinkmann, Kay, Chaplin, Paul, Suter, Mark, Hochrein, Hubertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753717/
https://www.ncbi.nlm.nih.gov/pubmed/23986761
http://dx.doi.org/10.3389/fimmu.2013.00251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753717/
https://www.ncbi.nlm.nih.gov/pubmed/23986761
http://dx.doi.org/10.3389/fimmu.2013.00251

Ejemplares similares